-
Product Insights
NewContinuous Positive Airway Pressure (CPAP) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
CPAP Devices Pipeline Market Report Overview A continuous positive airway pressure machine (CPAP) is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. CPAP devices provide gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose that is connected to a nasal mask, nasal pillow, or a full-face mask. The CPAP devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Myelodysplastic Syndrome Drug Details: Briquilimab (AMG-191) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Chronic Urticaria Or Hives report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Chronic Urticaria Or Hives Drug Details: Briquilimab (AMG-191)...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Acute Myelocytic Leukemia (AML,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avapritinib in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avapritinib in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avapritinib in Breast Cancer Drug Details: Avapritinib (Ayvakit, Ayvakyt) is an anti-neoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pexidartinib Hydrochloride in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pexidartinib Hydrochloride in Sarcomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pexidartinib Hydrochloride in Sarcomas Drug Details: Pexidartinib hydrochloride (Turalio) is an anti-neoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)...
-
Sector Analysis
NewBusiness of the Indian Premier League (IPL) 2024 – Property Profile, Sponsorship and Media Landscape
Indian Premier League (IPL) 2024 Report Overview The estimated sponsorship revenue of the Indian Premier League (IPL) is $99.31 million for the 2024 season. The 2024 IPL has five official sponsors, including Tata Group who have been the official title sponsor of the tournament since 2022. The partnership between Tata Group and the IPL also holds the highest annual value for the 17th edition of the tournament. The Indian Premier League (IPL) 2024 report provides an analysis of the current...